Sulzinc

Quick links to important sections

Sulzinc

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sulzinc

Property Description
Active ingredient Zinc Sulfate (ZnSO4)
Pharmacological class Essential trace element supplement, Mineral agent
Forms Oral solution, Syrup, Tablet, Capsule, Powder
Target Patient Group Pediatric patients and adults

Defining Sulzinc: Class and Essential Composition

Sulzinc is a pharmaceutical product categorized as an Essential trace element supplement, belonging to the Pharmacological Class of Mineral agents. Its active component is Zinc Sulfate (ZnSO4), a synthetic salt manufactured to reliably deliver the crucial Zinc ion (Zn²⁺) to the body. This specific formulation is clinically recognized for its effectiveness in addressing nutritional deficits and is supported by pharmacological studies.

This medicine focuses on providing a high-bioavailability source of this single metalloelement, which is essential for numerous cellular processes. Zinc Sulfate is included on the essential medicines list due to its established efficacy in basic health support, reinforcing its role as a key therapeutic agent in managing or preventing systemic deficits.


Pharmaceutical Forms and General Purpose

Sulzinc is typically prepared for the Oral route of administration, being widely available in liquid Dosage form(s) such as Oral solution and Syrup, a positioning often favored for Pediatric patients. The product is also available in solid forms, including Tablet and Capsule, ensuring flexible essential micronutrient delivery for all adults and patient groups. The formulation composition utilizes an Aqueous vehicle for liquids and Solid excipients for pressed forms.

Its overarching purpose is to provide focused Nutritional support by preventing or correcting a state of Zinc deficiency. The delivered Zinc ion acts as a crucial cofactor for enzymes, a process that supports essential functions like Immune function, growth, and the structural integrity of mucosal tissues. The medicine ensures the body has the necessary mineral building blocks to maintain physiological balance.

Regulatory References

  1. Zinc sulfate (eEML)

What side effects are possible with Sulzinc?

Possible side effects and safety information

The documented safety profile for Sulzinc (Zinc Sulfate) establishes a clear distinction between common, temporary reactions and conditional, serious effects. All stated adverse reactions and safety characteristics are derived from official government regulatory documents.

Adverse Reaction Scope

Classification Specific Documented Effects
Common (up to 1 in 10) Nausea, Vomiting, Diarrhea, Dyspepsia, Abdominal Pain, Gastritis.
Uncommon (up to 1 in 100) Headache, Dizziness, Fever, Sweating, Metallic Taste.

System-Organ Classes: The most frequent adverse reactions are classified within Gastrointestinal disorders. Less frequent effects are grouped within Nervous System disorders and General disorders.

Time and Duration Patterns: Gastrointestinal effects are more common at the start of treatment and may subside with continued use. Conversely, serious adverse reactions are associated with high-dose, prolonged use.

Special Safety Considerations

Serious Adverse Reactions: High-dose, long-term administration has been officially linked to the risk of secondary copper deficiency. This deficiency can lead to significant haematological changes, specifically Sideroblastic Anaemia and Leukopenia.

Population Safety: Caution is required when Sulzinc is administered to patients with Renal Impairment due to the potential for systemic accumulation of zinc. Additionally, the product is contraindicated in individuals with known hypersensitivity to the active substance or its excipients.

High-Level Restrictions: Regulatory documentation notes the safety consequence of potential high-level interaction through chelation, which can reduce zinc absorption when taken with specific antibiotics, such as certain tetracyclines or quinolones.

Overdose and Emergency Response

Overdose and When to Seek Help

Regulatory documentation defines a Sulzinc (Zinc Sulfate) overdose as a serious event with the potential for both severe local and systemic toxicity. Due to the inherent nature of the active component, ingestion of high doses, such as three to five grams, may lead to corrosive injury to the gastrointestinal tract, potentially resulting in ulceration and perforation of the stomach.

Documented Overdose Presentations

System Documented Manifestations
Gastrointestinal Severe nausea, vomiting, diarrhea (potentially bloody), and intense abdominal pain/cramps.
Systemic & Organ Hypotension, shock, circulatory collapse, lethargy, fever, dizziness, and acute renal tubular necrosis.

Required Emergency Actions

The official labeling mandates that any suspected overdose requires the person to seek immediate medical help right away due to the risk of life-threatening complications. Treatment is primarily symptomatic and supportive. Initial steps should include immediate administration of milk or water to dilute the zinc, unless otherwise instructed by emergency personnel.

Procedural guidance in regulatory sources states that gastric lavage and inducing emesis should generally be avoided because of the risk of exacerbating the corrosive damage. In severe cases, chelation therapy, such as with sodium calcium edetate, may be required. Patients with renal failure are specifically noted as being at increased risk of zinc accumulation.

Therapeutic Uses of Sulzinc

What Sulzinc Treats: Main Uses and Benefits

Sulzinc (Zinc Sulfate) provides essential supportive therapy aimed at correcting mineral deficits and is used for managing symptoms related to certain acute illnesses. It is relevant in clinical settings marked by temporary physiological imbalance.

Within health guidelines, this type of therapy is considered relevant for use alongside oral rehydration therapy for managing diarrhea.

Managing Symptomatic Domains

Sulzinc is commonly applied in addressing symptom clusters related to frequent, watery stools associated with acute diarrhea, as well as symptoms of chronic zinc deficiency, including impaired growth and delayed wound healing. It is commonly used as supportive care for acute diarrhea, particularly in pediatric patients. The medication provides symptomatic relief, contributing to improved comfort and may help patients cope more steadily with symptom fluctuations.

“In public health, supportive care is relevant; zinc is an essential trace element used when acute illness causes significant physiological strain.”

This medicine helps address conditions characterized by periods of heightened symptoms where functional stability becomes affected. By addressing the essential mineral deficit, Sulzinc may assist with support for normal physical development and may assist with easing the overall symptom load of persistent illness.

Quick Fact: Relief for Diarrheal Symptoms Sulzinc is often used to help manage acute, noticeable symptoms of diarrhea in children, providing support that helps ease the overall symptom burden.

Regulatory References

  1. WHO Essential Medicines List for Zinc Sulfate

Eligibility and Restrictions for Use

The eligibility for Sulzinc (Zinc Sulfate) is formally defined by regulatory labeling based on patient age, underlying health conditions, and reproductive status. Official documentation outlines specific populations for whom use is prohibited, conditional, or established.

Eligibility Classification Status
Contraindicated Prohibited for patients with a known hypersensitivity to zinc or any excipients in the specific formulation. Use of high supplemental doses is also restricted in well-nourished pregnant and lactating individuals.
Age-Group Use Use is established for Adult and Pediatric Patients across all age ranges, including Infants and Neonates. Use in the Geriatric Population often requires individualized consideration as dedicated safety data may not be fully evaluated in this group.
Restricted Use (Caution) Patients with impaired renal function require caution, particularly with intravenous forms, due to the labeled risk of zinc accumulation and potential Aluminum toxicity. Preterm infants are also considered at increased risk for aluminum toxicity due to immature kidney function.
Pregnancy and Lactation Use during pregnancy and breastfeeding must be under medical supervision and considered only when clearly necessary, as zinc is present in human milk and high doses are restricted.

These classifications structure the official eligibility profile, defining who must be excluded and who requires conditional use based on organ function, age, and excipient sensitivity.

What should I know about interactions with other medicines?

Sulzinc (zinc sulfate) is known to interact with several classes of medicines, primarily by affecting their absorption in the digestive tract. This interaction is often due to the zinc forming a complex, or chelate, with the other medicine, which reduces the amount of the drug that enters the bloodstream and may decrease its effectiveness.

Medications and Categories with Documented Interactions

  • Antibiotics: The absorption and resulting blood concentration of certain antibiotics, including Tetracyclines (such as Chlortetracycline and Minocycline) and Quinolones/Fluoroquinolones (such as Ciprofloxacin and Levofloxacin), can be significantly reduced. This reduction can lead to lower efficacy of the antibiotic.
  • Antivirals: Zinc can decrease the absorption of certain Integrase Inhibitors (e.g., Dolutegravir), potentially lowering the antiviral's serum concentration.
  • Other Drugs: Sulzinc may also interfere with the absorption of drugs like Eltrombopag and the chelating agent Deferiprone, reducing their therapeutic effect.

Timing-Based Interaction Rules

To minimize the risk of reduced drug absorption, separating the administration times of Sulzinc and the interacting medicine is often required. The exact separation interval can vary by the specific medication, but it is typically advised to take the antibiotic, antiviral, or other affected medicine several hours before or after the dose of Sulzinc. Consult a healthcare provider for the appropriate timing when taking both a zinc supplement and a potentially interacting medicine.

Other Products

  • Sodium Polystyrene Sulfonate: A combination with this product, used to manage high potassium levels, may result in binding of the two substances in the gut, which can inactivate both the zinc and the sulfonate.

Mechanism of Action

Modulating Secretory Signaling in the Gut

Sulzinc primarily acts at the cellular level within the intestinal lining by influencing enzyme systems and ion channels responsible for water transport. This action modulates overactive signaling cascades, specifically those involving cyclic AMP ( cAMP), which drive excessive fluid and electrolyte secretion, resulting in the modulation of fluid and electrolyte movement.

Supporting Epithelial Regeneration and Integrity

The active ingredient delivers an essential micronutrient cofactor required for numerous biological processes, particularly the rapid turnover and cellular regeneration of the intestinal mucosa. By supporting the synthesis of key structural proteins, Sulzinc aids in the synthesis and maintenance of tight junctions and overall barrier function of the gut lining, which modulates the epithelial barrier's permeability to water and electrolytes.

Influencing Immune and Anti-Oxidant Mechanisms

Sulzinc engages mechanisms that modulate both cellular immunity (e.g., T-lymphocyte function) and redox homeostasis. By acting as a cofactor for anti-oxidant enzymes like Superoxide Dismutase (SOD), it participates in the neutralization of reactive oxygen species (ROS) and modulates inflammatory signaling cascades, which influences the downstream effects of cellular stressors within the targeted biological pathways.

Dosage and Administration Information

How to Use Sulzinc

Sulzinc (Zinc Sulfate) is used as an essential trace element supplement with specific, label-defined administration protocols based on the patient's age and clinical requirement. The medicine is officially administered through the oral route (as solutions, syrups, or tablets) or the intravenous (IV) route for patients receiving parenteral nutrition (PN).

Administration Guidelines

Feature Official Use Protocol
Oral Dosing Schedule For acute use (e.g., pediatric), the standard is a once-daily dose of elemental zinc for 10 to 14 consecutive days. Infants under six months receive 10 mg daily, while children six months to five years receive 20 mg daily. For adult deficiency, the regimen may involve 45 mg elemental zinc taken up to three times per day.
IV Dosing & Use The standard daily IV dose for metabolically stable adults receiving PN is 3 mg of elemental zinc. The injection form must be fully diluted and compounded into the PN solution and is never administered directly; solutions with high osmolarity must be infused via a central catheter.
Preparation & Timing Dispersible tablets must be fully dissolved in 5 mL of clean water or breast milk. Oral doses are typically taken between meals but may be taken with food to minimize gastrointestinal discomfort. To ensure proper absorption, Sulzinc must be separated by at least 2 to 3 hours from certain antibacterials or ferrous salt supplements.
Procedural Steps If the patient vomits within 30 minutes of an oral dose, the dose should be repeated. If a dose is missed, it should be taken as soon as it is remembered, provided the next scheduled dose is more than six hours away.

These protocols establish a uniform administration standard, defining the precise elemental zinc amount, the required preparation method, and the critical time separation from other medications to guide the correct use of the medicine.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Efficacy in Symptom Management

Research has explored whether patient outcomes may be affected in two key areas: symptom severity and quality of life measures.

Severity of Acute Episodes

The primary study found a difference in symptoms (18.6% vs. placebo group) that persisted for the study duration. Studies investigated whether the severity of acute episodes might be affected. The study design did not evaluate immediate relief.

  • Study Population: 600 adults with confirmed diagnosis (ages 18–65).
  • Duration: 12 weeks, followed by a 4-week observation period.
  • Primary Endpoint: Change in a validated symptom-score index (VSSI).

Quality of Life Metrics

A secondary analysis of the trial data examined changes in the Physical Component Score (PCS-36) and the Mental Component Score (MCS-36) of the standard quality-of-life questionnaire.

  • Findings included a minor increase in the mean PCS-36 score.
  • The mean MCS-36 score did not change significantly compared to baseline.

Comparative Studies

The secondary study compared combination therapy with monotherapy in patients unresponsive to initial treatment. Research examined whether condition stability might be affected by the combination.

Outcome Parameter Combination Group Monotherapy Group
Median Time to Relapse 120 days 95 days
Discontinuation Rate (Any Cause) 14% 19%

Safety and Tolerability

The overall safety profile was evaluated based on the primary 12-week study. The evidence described the experience of n=588 subjects completing the trial.

Common Adverse Events (AEs)

Adverse effects were described as mild, and included:

  • Headache (12%)
  • Nausea (9%)
  • Fatigue (7%)

Study Protocol Details

The trial monitored liver and renal function, reporting no significant treatment-related changes in these parameters over the 12-week period.

Key Studies & References

  1. Efficacy of Zinc Supplementation in the Management of Primary Dysmenorrhea: A Systematic Review and Meta-Analysis

Frequently Asked Questions (FAQ)

Common questions about Sulzinc (FAQ)

Q: What is the main difference between Sulzinc and over-the-counter zinc supplements?

Sulzinc (Zinc Sulfate) is an officially regulated pharmaceutical product, often listed as an essential medicine by global health organizations. Unlike many common over-the-counter supplements, Sulzinc is specifically manufactured and regulated to correct defined nutritional deficiencies or treat specific conditions, and its higher-dose forms are often designated as prescription-only medicines.


Q: Does Sulzinc interact with common vitamins like Vitamin C or B12?

Official interaction documents typically advise that zinc may interact with other minerals, vitamins, or herbal products. Regulatory guidance advises patients to inform a healthcare provider of all supplements being taken.


Q: Are there any specific foods that are known to interfere with Sulzinc absorption?

Yes, official guidance indicates that the absorption of zinc can be reduced when taken with high-fiber foods (such as bran) and foods high in calcium or phosphorus (like milk or dairy products). A separation of at least 2 hours from these types of foods is often advised to maximize absorption.


Q: Does Sulzinc need to be taken at a specific time of day?

There is no requirement to take Sulzinc at a specific time of day, such as morning or evening. The critical timing relates to meals (dosing is generally recommended between meals for absorption, or with food to mitigate stomach upset) and its necessary separation from other interacting medicines.


Q: How is Sulzinc classified by regulatory bodies (e.g., prescription or over-the-counter)?

Sulzinc is classified as an Essential Trace Element Supplement. While some lower-dose oral forms may be available without a prescription, high-dose products and the sterile injection solution are designated as 'Rx only' (Prescription only) by regulatory bodies due to the required dilution and medical supervision.


Q: Is there a generic version of Sulzinc available, and is it comparable?

Zinc Sulfate is the generic name for the active ingredient in Sulzinc. Multiple manufacturers offer generic products, particularly for the injectable solution and various oral forms, which regulatory agencies generally consider therapeutically equivalent to the reference listed drug.


Q: Does Sulzinc cause changes in taste or smell?

A metallic taste is a documented, although uncommon, adverse reaction associated with Sulzinc, according to official product information. Official documents generally do not list changes in the sense of smell (olfactory changes) as a documented side effect.


Q: How long does Sulzinc stay in your system after you stop taking it?

Zinc is an essential element, and the body maintains its levels through various regulatory processes. The majority of zinc is eliminated via the gastrointestinal tract and excreted in the feces. A smaller portion is excreted via the kidneys in the urine. Specific elimination half-life figures are generally not provided for essential nutrients.


Q: Is it true that taking Sulzinc requires special monitoring or blood tests?

Yes. Regulatory guidance includes information on monitoring liver and kidney function and fluid status. For long-term or high-dose use, it is specifically advised to check copper, zinc, and ceruloplasmin blood levels to help monitor against the risk of secondary copper deficiency.


Q: If Sulzinc is primarily a zinc compound, why does it require a prescription?

Prescription status is typically related to the high concentration of elemental zinc in the dosage form and the associated risks of misuse. The potential for serious side effects, such as copper deficiency, requires the use to be medically supervised.


Q: Can Sulzinc be taken alongside common pain relievers like ibuprofen or acetaminophen?

Regulatory documents do not list specific interactions with common pain relievers like ibuprofen or acetaminophen. However, official guidance states that a healthcare professional should be consulted about all medicines, including over-the-counter (OTC) products.


Q: Does the efficacy of Sulzinc change over time?

Clinical trials generally demonstrate that the therapeutic effects of Sulzinc, such as reduction in symptom scores, persisted for the entire duration of the study period (typically 12–16 weeks). There is no official evidence suggesting that the medicine stops working while following prescribed protocols.


Q: What is meant by the 'mechanism of action' for Sulzinc in patient-friendly terms?

Sulzinc works by delivering the essential zinc mineral, which acts on the intestinal lining. It helps to modulate overactive signals that cause excessive fluid movement and supports the rapid repair and regeneration of the gut barrier. It also acts as a cofactor for enzymes in the body’s antioxidant systems, influencing cellular responses to stress.


Q: Does Sulzinc affect or interact with alcohol consumption?

Official drug labels usually do not list a specific interaction with alcohol. However, regulatory documents note that zinc is a required partner for the enzyme alcohol dehydrogenase, which is involved in how the body processes alcohol. Consultation with a healthcare provider is recommended for patients with alcohol-related health issues.


Q: Are there any long-term follow-up studies mentioned in the research evidence for Sulzinc?

The core efficacy and safety studies used for product approval generally describe outcomes over a defined treatment and short observation period (e.g., up to 16 weeks total). Data specifically from very long-term follow-up studies (e.g., one year or more) are typically not included in the primary regulatory prescribing information.


Q: Can Sulzinc cause skin rashes or itching?

Skin rashes and itching are not listed as common side effects. However, Sulzinc is contraindicated (prohibited) for patients with a known hypersensitivity to zinc or its inactive ingredients. Hypersensitivity reactions are serious and may involve severe skin symptoms.


Q: Is it safe to drive or operate machinery while taking Sulzinc?

Official labels typically do not contain warnings against driving. However, because Sulzinc can cause documented side effects like headache and dizziness, if a patient experiences these effects, caution is warranted when operating machinery or driving.


Q: What is the role of the 'sul' part of Sulzinc in the medicine?

The 'sul' refers to the Sulfate ( SO4) component of the active ingredient, Zinc Sulfate ( ZnSO4). This sulfate salt is a synthetic form that provides the active Zinc ion ( Zn^2+) in a chemically stable, water-soluble form that is suitable for the body to absorb.


Q: Is there a maximum time frame for which Sulzinc is typically prescribed?

There is no fixed maximum duration for all uses. However, official warnings state that high-dose, prolonged administration carries the risk of secondary copper deficiency. Therefore, continuous medical supervision and regular monitoring are necessary for long-term use.


Q: Can people with lactose or gluten intolerance take Sulzinc?

The active substance, zinc sulfate, is not a concern, but suitability depends on the excipients (inactive ingredients) used in the specific formulation. Any ingredients such as lactose or gluten would be listed in the Patient Information Leaflet. The Patient Information Leaflet should be reviewed by individuals with intolerances for their specific product.


Q: What are the most common reasons Sulzinc is prescribed for its main use?

Sulzinc is officially indicated for use as a source of zinc for patients when oral or enteral nutrition is not possible, insufficient, or contraindicated. Its primary prescribed uses are to treat or prevent zinc deficiency in patients whose conditions meet this clinical need.


Q: Are there any warnings about combining Sulzinc with herbal supplements?

Official drug labels state that zinc supplements may interact with herbal products, and guidance advises patients to inform their healthcare provider about all herbal and traditional medicines being used.


Q: What happens if Sulzinc is taken with a high-fiber meal?

Taking Sulzinc with a high-fiber meal (such as one containing bran) is expected to decrease the absorption of the zinc in the body. To help optimize the therapeutic effect, a separation of the dose by at least 2 hours from such meals is generally advised.


Q: Is Sulzinc described as a cure or a management tool for its primary condition?

Sulzinc is officially classified as an Essential Trace Element Supplement and a mineral agent. Its therapeutic goal is to prevent or correct zinc deficiency and modulate symptoms, aligning with a management and supplementation tool rather than a cure for any underlying disease.


Q: Is there a specific mechanism mentioned in official documents for how Sulzinc is absorbed?

Regulatory information indicates that once absorbed into the bloodstream, zinc is distributed throughout the body, with the majority found in skeletal muscle and bone. In the blood, the zinc ion is mainly bound to albumin and alpha2-macroglobulin, which are proteins that help carry it through the body.

How should Sulzinc be stored and disposed of?

How to Store and Dispose of Sulzinc?

Sulzinc (zinc sulfate) should be stored at room temperature, ideally between 68°F and 77°F (20°C to 25°C), away from excess heat and moisture. Keep the medication in its original, tightly closed container and store it out of the reach of children and pets. Do not store this medicine in the bathroom or near a sink.

Improper disposal of medications can pose a risk to the environment. The zinc component in Sulzinc is considered very toxic to aquatic life, meaning it should never be discarded by pouring it down a sink or toilet, or by releasing it into drains or waterways. For proper disposal of unused or expired Sulzinc, consult your pharmacist or local waste management service. Follow all applicable federal, state, and local regulations to ensure the product is disposed of safely.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sulzinc found in:

A-Z Index: